-
Net income increases to
$1.64 per diluted share from$1.37 in the first quarter of 2017. -
First quarter results include a net benefit of
$0.38 per diluted share for the net impact of the reconciliation of 2017 Marketplace cost sharing reduction (CSR) subsidies and other items not included in the Company’s preliminary 2018 guidance. First quarter 2017 results had included a benefit of$0.84 per diluted share from the termination fee for a proposed acquisition. - Premium revenue decreases 7.0% compared with the first quarter of 2017, as expected with the Company’s repositioning of Marketplace operations.
- Medical care ratio decreases to 86.1% from 88.4% in the first quarter of 2017.
- General and administrative expense ratio decreases to 7.6% from 8.9% in the first quarter of 2017.
-
2018 guidance increased by
$1.00 per diluted share to a range of$4 .00–$4.50 net income per diluted share and$4 .24–$4.74 adjusted net income per diluted share. -
Revised 2018 guidance includes the net benefit of
$0.38 per diluted share for items noted above that were not included in the Company’s preliminary 2018 guidance and$0.62 per diluted share in improved performance against the Company’s original internal estimates for the full year of 2018.
“The financial results that we announced today reflect the progress we
are making towards our goal of sustainable margin recovery,” said
First Quarter 2018 Highlights |
||||||||
Three Months Ended March 31, | ||||||||
2018 | 2017 | |||||||
(In millions, except per-share amounts) | ||||||||
Premium revenue | $ | 4,323 | $ | 4,648 | ||||
Operating income | $ | 222 | $ | 82 | ||||
Net income | $ | 107 | $ | 77 | ||||
Net income per diluted share | $ | 1.64 | $ | 1.37 | ||||
Diluted weighted average shares outstanding | 65.2 | 56.2 | ||||||
Operating Statistics: | ||||||||
Medical care ratio (1) | 86.1 | % | 88.4 | % | ||||
G&A ratio (2) | 7.6 | % | 8.9 | % | ||||
Premium tax ratio (1) | 2.3 | % | 2.3 | % | ||||
Effective income tax expense rate | 40.3 | % | 41.6 | % | ||||
Net profit margin (2) | 2.3 | % | 1.6 | % | ||||
__________________ | ||
(1) | Medical care ratio represents medical care costs as a percentage of premium revenue; premium tax ratio represents premium tax expenses as a percentage of premium revenue plus premium tax revenue. | |
(2) | G&A ratio represents general and administrative expenses as a percentage of total revenue. Net profit margin represents net income as a percentage of total revenue. | |
Summary of Significant Items Affecting Comparative First Quarter Financial Results
The table below summarizes the impact of certain items significant to the Company’s financial performance in the periods presented. The individual items presented below increase (decrease) income before income tax expense.
Three Months Ended March 31, | |||||||||||||||
2018 | 2017 | ||||||||||||||
Per |
Per |
||||||||||||||
Diluted |
Diluted |
||||||||||||||
Amount |
Share(1) |
Amount |
Share(1) |
||||||||||||
(In millions, except per diluted share amounts) | |||||||||||||||
Reimbursement of Marketplace CSR subsidies, for 2017 dates of service | $ | 70 | $ | 0.83 | $ | — | $ | — | |||||||
Restructuring costs | (25 | ) | (0.30 | ) | — | — | |||||||||
Loss on debt extinguishment | (10 | ) | (0.15 | ) | — | — | |||||||||
Fee received for terminated acquisition | — | — | 75 | 0.84 | |||||||||||
$ | 35 | $ | 0.38 | $ | 75 | $ | 0.84 | ||||||||
__________________ | ||
(1) | Except for certain items that are not deductible for tax purposes, per diluted share amounts are generally calculated at statutory income tax rates of 22% and 37% for the first quarters of 2018 and 2017, respectively. | |
First Quarter of 2018 Compared With First Quarter of 2017
Net income for the first quarter of 2018 was
Net income for the first quarter of 2018 included a net benefit of
Premium revenue decreased approximately 7% when compared with the first
quarter of 2017. Lower premium revenue was driven by a decrease in
Marketplace membership of over 50%, partially offset by Marketplace
premium rate increases. As previously disclosed, the Company has
increased premium rates and reduced its Marketplace presence effective
Overall, the medical care ratio decreased to 86.1%, from 88.4% in the first quarter of 2017. Excluding the benefit of the 2017 CSR reimbursement, the consolidated medical care ratio was 87.7% in the first quarter of 2018.
-
The medical care ratio for the
Medicaid andMedicare programs combined decreased to 90.0%, from 91.0% in the first quarter of 2017. Improved performance at theFlorida ,Illinois ,Ohio andSouth Carolina health plans, partially offset by a decline in performance at theWashington health plan, drove the decrease in the consolidated medical care ratio forMedicaid andMedicare combined. The 2017 CSR reimbursement had no impact on the medical care ratio for the Company’sMedicaid andMedicare programs. -
The medical care ratio for the Company’s Marketplace operations was
50.6% for the first quarter of 2018. Excluding the impact of the 2017
Marketplace CSR adjustment noted below, the medical care ratio for
Marketplace operations decreased to approximately 67%, from 75% in the
first quarter of 2017. Improved profitability in Marketplace
operations is primarily the result of premium increases implemented
effective
January 1, 2018 .
The general and administrative (G&A) expense ratio decreased to 7.6%, from 8.9% in the first quarter of 2017. Excluding the impact of Marketplace broker commissions and exchange fees in both periods, the G&A ratio decreased to 6.8%, from 7.5% in the first quarter of 2017.
The Company recognized a benefit of approximately
Approximately
Approximately
2018 Revised Guidance
The following table summarizes 2018 Revised Guidance (1):
Revised | Preliminary | ||||
Premium revenue | ~ $17.4B | ~ $17.5B | |||
Service revenue | ~ $525M | ~ $525M | |||
Premium tax revenue | ~ $425M | ~ $410M | |||
Health insurer fees reimbursed | ~ $280M | ~ $295M | |||
Investment income and other revenue | ~ $110M | ~ $85M | |||
Total revenue | ~ $18.7B | ~ $18.8B | |||
Medical care costs | ~$15.4B | ~$15.6B | |||
Medical care ratio (2) | 88% - 89% | ~ 89% | |||
Cost of service revenue | ~ $480M | ~ $480M | |||
General and administrative expenses | ~ $1.4B | ~ $1.4B | |||
G&A ratio (3) | ~ 7.4% | ~ 7.3% | |||
Premium tax expenses | ~$425M | ~$410M | |||
Health insurer fees | ~ $300M | ~ $310M | |||
Depreciation and amortization | ~ $115M | ~ $115M | |||
Restructuring and separation costs | ~ $25M | — | |||
Interest expense and other income, net | ~ $135M | ~ $125M | |||
Income before income taxes | $450M - $495M | $355M - $400M | |||
Net income | $272M - $306M | $202M - $236M | |||
EBITDA (4) | $724M - $768M | $632M - $676M | |||
Effective tax rate | 38% - 40% | 41% - 43% | |||
Net profit margin (3) | 1.5% - 1.6% | 1.1% - 1.3% | |||
Diluted weighted average shares | ~ 68.0M | ~ 67.3M | |||
Net income per share | $4.00 - $4.50 | $3.00 - $3.50 | |||
Adjusted net income per share (4) | $4.24 - $4.74 | $3.23 - $3.73 | |||
End-of-year Marketplace membership | 356,000 | 303,000 | |||
End-of-year Non-Marketplace membership | 3,674,000 | 3,738,000 | |||
__________________ | ||
(1) | All amounts are estimates; actual results may differ materially. See the Company’s risk factors as discussed in its 2017 Form 10-K and other filings and the statements below in this press release after the heading “Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995.” | |
(2) | Medical care ratio represents medical care costs as a percentage of premium revenue. | |
(3) | G&A ratio represents general and administrative expenses as a percentage of total revenue. Net profit margin represents net income as a percentage of total revenue. | |
(4) | See reconciliation of non-GAAP financial measures at the end of this release. | |
Conference Call
Management will host a conference call and webcast to discuss Molina
Healthcare’s first quarter 2018 results at
About
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This earnings release contains “forward-looking statements” regarding the Company’s 2018 revised guidance, as well as its plans, expectations, and anticipated future events. Actual results could differ materially due to numerous known and unknown risks and uncertainties. Those known risks and uncertainties include, but are not limited to, the following:
- the success of the Company’s profit improvement and maintenance initiatives, including the timing and amounts of the benefits realized, and administrative savings achieved;
- the numerous political and market-based uncertainties associated with the Affordable Care Act (the “ACA”) or “Obamacare;”
- the market dynamics surrounding the ACA Marketplaces, including but not limited to uncertainties associated with risk transfer requirements, the potential for disproportionate enrollment of higher acuity members, the discontinuation of premium tax credits, and the adequacy of agreed rates;
- subsequent adjustments to reported premium revenue based upon subsequent developments or new information, including changes to estimated amounts payable or receivable related to Marketplace risk adjustment/risk transfer;
- effective management of the Company’s medical costs;
- the Company’s ability to predict with a reasonable degree of accuracy utilization rates, including utilization rates associated with seasonal flu patterns or other newly emergent diseases;
- significant budget pressures on state governments and their potential inability to maintain current rates, to implement expected rate increases, or to maintain existing benefit packages or membership eligibility thresholds or criteria;
- the full reimbursement of the ACA health insurer fee, or HIF;
- the success of the Company’s efforts to retain existing government
contracts, including those in
Florida ,New Mexico ,Puerto Rico ,Texas , andWashington , including the success of any protest filings; - the Company’s ability to manage its operations, including maintaining and creating adequate internal systems and controls relating to authorizations, approvals, provider payments, and the overall success of its care management initiatives;
- the Company’s ability to consummate and realize benefits from acquisitions or divestitures;
- the Company’s receipt of adequate premium rates to support increasing pharmacy costs, including costs associated with specialty drugs and costs resulting from formulary changes that allow the option of higher-priced non-generic drugs;
- the Company’s ability to operate profitably in an environment where the trend in premium rate increases lags behind the trend in increasing medical costs;
- the interpretation and implementation of federal or state medical cost expenditure floors, administrative cost and profit ceilings, premium stabilization programs, profit sharing arrangements, and risk adjustment provisions and requirements;
- the Company’s estimates of amounts owed for such cost expenditure floors, administrative cost and profit ceilings, premium stabilization programs, profit-sharing arrangements, and risk adjustment provisions;
- the
Medicaid expansion cost corridors inCalifornia ,New Mexico , andWashington , and any other retroactive adjustment to revenue where methodologies and procedures are subject to interpretation or dependent upon information about the health status of participants other than Molina members; - the interpretation and implementation of at-risk premium rules and state contract performance requirements regarding the achievement of certain quality measures, and the Company’s ability to recognize revenue amounts associated therewith;
- cyber-attacks or other privacy or data security incidents resulting in an inadvertent unauthorized disclosure of protected health information;
- the success of the Company’s health plan in
Puerto Rico , including the resolution of thePuerto Rico debt crisis, payment of all amounts due under the Company’sMedicaid contract, the effect of the PROMESA law, the impact of Hurricane Maria and the Company’s efforts to better manage the health care costs of itsPuerto Rico health plan; - the success and renewal of the Company’s duals demonstration
programs in
California ,Illinois ,Michigan ,Ohio ,South Carolina , andTexas ; - the accurate estimation of incurred but not reported or paid medical costs across the Company’s health plans;
- efforts by states to recoup previously paid and recognized premium amounts;
- complications, member confusion, or enrollment backlogs related to
the annual renewal of
Medicaid coverage; - government audits and reviews, or potential investigations, and any fine, sanction, enrollment freeze, monitoring program, or premium recovery that may result therefrom;
- changes with respect to the Company’s provider contracts and the loss of providers;
- approval by state regulators of dividends and distributions by the Company’s health plan subsidiaries;
- changes in funding under the Company’s contracts as a result of regulatory changes, programmatic adjustments, or other reforms;
- high dollar claims related to catastrophic illness;
- the favorable resolution of litigation, arbitration, or administrative proceedings;
- the relatively small number of states in which we operate health
plans, including the greater scale and revenues of the Company’s
California ,Ohio ,Texas , andWashington health plans; - the availability of adequate financing on acceptable terms to fund and capitalize the Company’s expansion and growth, repay the Company’s outstanding indebtedness at maturity and meet its liquidity needs, including the interest expense and other costs associated with such financing;
- the Company’s failure to comply with the financial or other covenants in its credit agreements or the indentures governing its outstanding notes;
- the sufficiency of the Company’s funds on hand to pay the amounts due upon conversion or maturity of its outstanding notes;
- the failure of a state in which we operate to renew its federal
Medicaid waiver; - changes generally affecting the managed care or
Medicaid management information systems industries; - increases in government surcharges, taxes, and assessments, including but not limited to the deductibility of certain compensation costs;
- newly emergent viruses or widespread epidemics, public catastrophes or terrorist attacks, and associated public alarm;
- increasing competition and consolidation in the
Medicaid industry;
and numerous other risk factors, including those discussed in the
Company’s periodic reports and filings with the
MOLINA HEALTHCARE, INC. | ||||||||
UNAUDITED CONSOLIDATED STATEMENTS OF INCOME | ||||||||
Three Months Ended March 31, | ||||||||
2018 | 2017 | |||||||
(Dollar amounts in millions, except per-share amounts) | ||||||||
Revenue: | ||||||||
Premium revenue | $ | 4,323 | $ | 4,648 | ||||
Service revenue | 134 | 131 | ||||||
Premium tax revenue | 104 | 111 | ||||||
Health insurer fees reimbursed | 61 | — | ||||||
Investment income and other revenue | 24 | 14 | ||||||
Total revenue | 4,646 | 4,904 | ||||||
Operating expenses: | ||||||||
Medical care costs | 3,722 | 4,111 | ||||||
Cost of service revenue | 120 | 122 | ||||||
General and administrative expenses | 352 | 439 | ||||||
Premium tax expenses | 104 | 111 | ||||||
Health insurer fees | 75 | — | ||||||
Depreciation and amortization | 26 | 39 | ||||||
Restructuring and separation costs | 25 | — | ||||||
Total operating expenses | 4,424 | 4,822 | ||||||
Operating income | 222 | 82 | ||||||
Other expenses (income), net: | ||||||||
Interest expense | 33 | 26 | ||||||
Other expense (income), net | 10 | (75 | ) | |||||
Total other expenses (income), net | 43 | (49 | ) | |||||
Income before income tax expense | 179 | 131 | ||||||
Income tax expense | 72 | 54 | ||||||
Net income | $ | 107 | $ | 77 | ||||
Net income per diluted share | $ | 1.64 | $ | 1.37 | ||||
Diluted weighted average shares outstanding | 65.2 | 56.2 | ||||||
Operating Statistics: | ||||||||
Medical care ratio | 86.1 | % | 88.4 | % | ||||
G&A ratio | 7.6 | % | 8.9 | % | ||||
Premium tax ratio | 2.3 | % | 2.3 | % | ||||
Effective income tax expense rate | 40.3 | % | 41.6 | % | ||||
Net profit margin | 2.3 | % | 1.6 | % | ||||
MOLINA HEALTHCARE, INC. | ||||||||
UNAUDITED CONSOLIDATED BALANCE SHEETS | ||||||||
March 31, | December 31, | |||||||
2018 | 2017 | |||||||
(In millions, except per-share data) |
||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 3,729 | $ | 3,186 | ||||
Investments | 2,444 | 2,524 | ||||||
Restricted investments | 77 | 169 | ||||||
Receivables | 950 | 871 | ||||||
Prepaid expenses and other current assets | 411 | 239 | ||||||
Derivative asset | 585 | 522 | ||||||
Total current assets | 8,196 | 7,511 | ||||||
Property, equipment, and capitalized software, net | 318 | 342 | ||||||
Goodwill and intangible assets, net | 250 | 255 | ||||||
Restricted investments | 120 | 119 | ||||||
Deferred income taxes | 114 | 103 | ||||||
Other assets | 135 | 141 | ||||||
$ | 9,133 | $ | 8,471 | |||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Medical claims and benefits payable | $ | 2,023 | $ | 2,192 | ||||
Amounts due government agencies | 1,714 | 1,542 | ||||||
Accounts payable and accrued liabilities | 713 | 366 | ||||||
Deferred revenue | 404 | 282 | ||||||
Current portion of long-term debt | 566 | 653 | ||||||
Derivative liability | 585 | 522 | ||||||
Total current liabilities | 6,005 | 5,557 | ||||||
Long-term debt | 1,318 | 1,318 | ||||||
Lease financing obligations | 198 | 198 | ||||||
Other long-term liabilities | 59 | 61 | ||||||
Total liabilities | 7,580 | 7,134 | ||||||
Stockholders’ equity: | ||||||||
Common stock, $0.001 par value, 150 shares authorized; outstanding: 62 shares at March 31, 2018 and 60 shares at December 31, 2017 | — | — | ||||||
Preferred stock, $0.001 par value; 20 shares authorized, no shares issued and outstanding | — | — | ||||||
Additional paid-in capital | 1,153 | 1,044 | ||||||
Accumulated other comprehensive loss | (12 | ) | (5 | ) | ||||
Retained earnings | 412 | 298 | ||||||
Total stockholders’ equity | 1,553 | 1,337 | ||||||
$ | 9,133 | $ | 8,471 | |||||
MOLINA HEALTHCARE, INC. | ||||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
Three Months Ended March 31, | ||||||||
2018 | 2017 | |||||||
(In millions) | ||||||||
Operating activities: | ||||||||
Net income | $ | 107 | $ | 77 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 37 | 49 | ||||||
Deferred income taxes | (6 | ) | (5 | ) | ||||
Share-based compensation | 6 | 6 | ||||||
Non-cash restructuring charges | 17 | — | ||||||
Amortization of convertible senior notes and lease financing obligations | 7 | 8 | ||||||
Loss on debt extinguishment | 10 | — | ||||||
Other, net | 2 | 3 | ||||||
Changes in operating assets and liabilities: | ||||||||
Receivables | (83 | ) | (32 | ) | ||||
Prepaid expenses and other current assets | (239 | ) | (12 | ) | ||||
Medical claims and benefits payable | (163 | ) | (3 | ) | ||||
Amounts due government agencies | 172 | 373 | ||||||
Accounts payable and accrued liabilities | 319 | 50 | ||||||
Deferred revenue | 130 | 146 | ||||||
Income taxes | 78 | 59 | ||||||
Net cash provided by operating activities | 394 | 719 | ||||||
Investing activities: | ||||||||
Purchases of investments | (389 | ) | (733 | ) | ||||
Proceeds from sales and maturities of investments | 543 | 433 | ||||||
Purchases of property, equipment, and capitalized software | (4 | ) | (26 | ) | ||||
Increase in restricted investments held-to-maturity | — | (5 | ) | |||||
Other, net | (5 | ) | (6 | ) | ||||
Net cash provided by (used in) investing activities | 145 | (337 | ) | |||||
Financing activities: | ||||||||
Cash paid for financing transaction fees | (5 | ) | — | |||||
Proceeds from employee stock plans | — | 1 | ||||||
Other, net | — | (2 | ) | |||||
Net cash used in financing activities | (5 | ) | (1 | ) | ||||
Net increase in cash, cash equivalents, and restricted cash and cash equivalents | 534 | 381 | ||||||
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period | 3,290 | 2,912 | ||||||
Cash, cash equivalents, and restricted cash and cash equivalents at end of period | $ | 3,824 | $ | 3,293 | ||||
MOLINA HEALTHCARE, INC. | ||||||||
UNAUDITED HEALTH PLANS SEGMENT MEMBERSHIP | ||||||||
March 31, | December 31, | March 31, | ||||||
2018 | 2017 | 2017 | ||||||
Ending Membership by Program: | ||||||||
Temporary Assistance for Needy Families (TANF) and Children’s Health Insurance Program (CHIP) | 2,435,000 | 2,457,000 | 2,548,000 | |||||
Medicaid Expansion | 662,000 | 668,000 | 684,000 | |||||
Aged, Blind or Disabled (ABD) | 411,000 | 412,000 | 401,000 | |||||
Total Medicaid | 3,508,000 | 3,537,000 | 3,633,000 | |||||
Medicare-Medicaid Plan (MMP) - Integrated | 56,000 | 57,000 | 55,000 | |||||
Medicare Special Needs Plans | 44,000 | 44,000 | 43,000 | |||||
Total Medicare | 100,000 | 101,000 | 98,000 | |||||
Excluding Marketplace | 3,608,000 | 3,638,000 | 3,731,000 | |||||
Marketplace | 453,000 | 815,000 | 1,035,000 | |||||
4,061,000 | 4,453,000 | 4,766,000 | ||||||
Ending Membership by Health Plan: | ||||||||
California | 656,000 | 746,000 | 765,000 | |||||
Florida | 414,000 | 625,000 | 711,000 | |||||
Idaho (1) | 2,000 | — | — | |||||
Illinois | 151,000 | 165,000 | 194,000 | |||||
Michigan | 388,000 | 398,000 | 417,000 | |||||
New Mexico | 250,000 | 253,000 | 270,000 | |||||
New York | 32,000 | 32,000 | 34,000 | |||||
Ohio | 328,000 | 327,000 | 351,000 | |||||
Puerto Rico | 316,000 | 314,000 | 326,000 | |||||
South Carolina | 117,000 | 116,000 | 111,000 | |||||
Texas | 476,000 | 430,000 | 493,000 | |||||
Utah | 90,000 | 152,000 | 172,000 | |||||
Washington | 779,000 | 777,000 | 785,000 | |||||
Wisconsin | 62,000 | 118,000 | 137,000 | |||||
4,061,000 | 4,453,000 | 4,766,000 | ||||||
__________________ | ||
(1) | Idaho operations commenced January 1, 2018. | |
MOLINA HEALTHCARE, INC. | |||||||||||||||||||||||||
UNAUDITED SELECTED HEALTH PLANS SEGMENT FINANCIAL DATA | |||||||||||||||||||||||||
(In millions, except percentages and per-member per-month amounts) |
|||||||||||||||||||||||||
Three Months Ended March 31, 2018 | |||||||||||||||||||||||||
Member Months (1) |
Premium Revenue | Medical Care Costs | MCR (2) |
Medical Margin |
|||||||||||||||||||||
Total | PMPM | Total | PMPM | ||||||||||||||||||||||
TANF and CHIP | 7.4 | $ | 1,373 | $ | 185.14 | $ | 1,272 | $ | 171.56 | 92.7 | % | $ | 101 | ||||||||||||
Medicaid Expansion | 2.0 | 752 | 372.75 | 641 | 317.46 | 85.2 | 111 | ||||||||||||||||||
ABD | 1.2 | 1,254 | 1,014.23 | 1,155 | 934.55 | 92.1 | 99 | ||||||||||||||||||
Total Medicaid | 10.6 | 3,379 | 316.69 | 3,068 | 287.56 | 90.8 | 311 | ||||||||||||||||||
MMP | 0.2 | 357 | 2,137.88 | 305 | 1,824.21 | 85.3 | 52 | ||||||||||||||||||
Medicare | 0.1 | 157 | 1,188.97 | 131 | 994.81 | 83.7 | 26 | ||||||||||||||||||
Total Medicare | 0.3 | 514 | 1,718.61 | 436 | 1,457.75 | 84.8 | 78 | ||||||||||||||||||
Non-Marketplace | 10.9 | 3,893 | 354.94 | 3,504 | 319.48 | 90.0 | 389 | ||||||||||||||||||
Marketplace | 1.4 | 430 | 312.87 | 218 | 158.40 | 50.6 | 212 | ||||||||||||||||||
12.3 | $ | 4,323 | $ | 350.25 | $ | 3,722 | $ | 301.55 | 86.1 | % | $ | 601 | |||||||||||||
Three Months Ended March 31, 2017 | |||||||||||||||||||||||||
Member Months (1) |
Premium Revenue | Medical Care Costs | MCR (2) |
Medical Margin |
|||||||||||||||||||||
Total | PMPM | Total | PMPM | ||||||||||||||||||||||
TANF and CHIP | 7.7 | $ | 1,402 | $ | 182.69 | $ | 1,304 | $ | 170.02 | 93.1 | % | $ | 98 | ||||||||||||
Medicaid Expansion | 2.0 | 817 | 398.70 | 689 | 336.51 | 84.4 | 128 | ||||||||||||||||||
ABD | 1.2 | 1,196 | 1,006.84 | 1,130 | 951.32 | 94.5 | 66 | ||||||||||||||||||
Total Medicaid | 10.9 | 3,415 | 312.98 | 3,123 | 286.35 | 91.5 | 292 | ||||||||||||||||||
MMP | 0.2 | 344 | 2,088.96 | 307 | 1,859.41 | 89.0 | 37 | ||||||||||||||||||
Medicare | 0.1 | 138 | 1,068.20 | 117 | 902.67 | 84.5 | 21 | ||||||||||||||||||
Total Medicare | 0.3 | 482 | 1,640.63 | 424 | 1,439.20 | 87.7 | 58 | ||||||||||||||||||
Non-Marketplace | 11.2 | 3,897 | 347.84 | 3,547 | 316.62 | 91.0 | 350 | ||||||||||||||||||
Marketplace | 2.9 | 751 | 262.16 | 564 | 196.72 | 75.0 | 187 | ||||||||||||||||||
14.1 | $ | 4,648 | $ | 330.39 | $ | 4,111 | $ | 292.20 | 88.4 | % | $ | 537 | |||||||||||||
__________________ | ||
(1) | A member month is defined as the aggregate of each month’s ending membership for the period presented. | |
(2) | The MCR represents medical costs as a percentage of premium revenue. | |
MOLINA HEALTHCARE, INC. | ||||||||||||||||||||||||||
UNAUDITED SELECTED HEALTH PLANS SEGMENT FINANCIAL DATA—NON-MARKETPLACE | ||||||||||||||||||||||||||
(In millions, except percentages and per-member per-month amounts) |
||||||||||||||||||||||||||
Three Months Ended March 31, 2018 | ||||||||||||||||||||||||||
Member Months |
Premium Revenue | Medical Care Costs | MCR |
Medical Margin |
||||||||||||||||||||||
Total | PMPM | Total | PMPM | |||||||||||||||||||||||
California | 1.8 | $ | 494 | $ | 272.61 | $ | 412 | $ | 227.31 | 83.4 | % | $ | 82 | |||||||||||||
Florida | 1.0 | 382 | 351.58 | 345 | 317.41 | 90.3 | 37 | |||||||||||||||||||
Idaho (1) | — | 4 | 960.33 | 4 | 977.00 | 101.8 | — | |||||||||||||||||||
Illinois | 0.5 | 141 | 298.17 | 122 | 257.50 | 86.4 | 19 | |||||||||||||||||||
Michigan | 1.1 | 376 | 336.64 | 331 | 296.19 | 88.0 | 45 | |||||||||||||||||||
New Mexico | 0.7 | 319 | 466.17 | 310 | 453.30 | 97.2 | 9 | |||||||||||||||||||
New York | 0.1 | 46 | 468.91 | 39 | 396.76 | 84.6 | 7 | |||||||||||||||||||
Ohio | 0.9 | 551 | 576.60 | 460 | 481.26 | 83.5 | 91 | |||||||||||||||||||
Puerto Rico | 1.0 | 186 | 193.13 | 174 | 181.39 | 93.9 | 12 | |||||||||||||||||||
South Carolina | 0.3 | 122 | 348.08 | 104 | 297.52 | 85.5 | 18 | |||||||||||||||||||
Texas | 0.7 | 562 | 809.90 | 519 | 747.53 | 92.3 | 43 | |||||||||||||||||||
Utah | 0.3 | 92 | 339.71 | 77 | 284.61 | 83.8 | 15 | |||||||||||||||||||
Washington | 2.3 | 584 | 256.66 | 574 | 252.41 | 98.3 | 10 | |||||||||||||||||||
Wisconsin | 0.2 | 34 | 183.97 | 29 | 154.53 | 84.0 | 5 | |||||||||||||||||||
Other (2) | — | — | — | 4 | — | — | (4 | ) | ||||||||||||||||||
10.9 | $ | 3,893 | $ | 354.94 | $ | 3,504 | $ | 319.48 | 90.0 | % | $ | 389 | ||||||||||||||
Three Months Ended March 31, 2017 | ||||||||||||||||||||||||||
Member Months |
Premium Revenue | Medical Care Costs | MCR |
Medical Margin |
||||||||||||||||||||||
Total | PMPM | Total | PMPM | |||||||||||||||||||||||
California | 1.8 | $ | 572 | $ | 308.57 | $ | 484 | $ | 261.31 | 84.7 | % | $ | 88 | |||||||||||||
Florida | 1.1 | 364 | 339.30 | 352 | 328.45 | 96.8 | 12 | |||||||||||||||||||
Idaho (1) | — | — | — | — | — | — | — | |||||||||||||||||||
Illinois | 0.6 | 161 | 276.58 | 180 | 310.08 | 112.1 | (19 | ) | ||||||||||||||||||
Michigan | 1.2 | 382 | 327.41 | 333 | 284.58 | 86.9 | 49 | |||||||||||||||||||
New Mexico | 0.7 | 308 | 422.87 | 299 | 410.75 | 97.1 | 9 | |||||||||||||||||||
New York | 0.1 | 46 | 441.19 | 42 | 409.63 | 92.8 | 4 | |||||||||||||||||||
Ohio | 1.0 | 520 | 527.79 | 462 | 469.04 | 88.9 | 58 | |||||||||||||||||||
Puerto Rico | 1.0 | 183 | 186.51 | 165 | 168.18 | 90.2 | 18 | |||||||||||||||||||
South Carolina | 0.3 | 105 | 317.07 | 98 | 293.34 | 92.5 | 7 | |||||||||||||||||||
Texas | 0.7 | 527 | 751.86 | 489 | 696.43 | 92.6 | 38 | |||||||||||||||||||
Utah | 0.3 | 89 | 313.20 | 72 | 253.75 | 81.0 | 17 | |||||||||||||||||||
Washington | 2.2 | 605 | 273.18 | 535 | 241.77 | 88.5 | 70 | |||||||||||||||||||
Wisconsin | 0.2 | 33 | 165.40 | 27 | 135.91 | 82.2 | 6 | |||||||||||||||||||
Other (2) | — | 2 | — | 9 | — | — | (7 | ) | ||||||||||||||||||
11.2 | $ | 3,897 | $ | 347.84 | $ | 3,547 | $ | 316.62 | 91.0 | % | $ | 350 | ||||||||||||||
__________________ | ||
(1) | Idaho operations commenced January 1, 2018. | |
(2) | “Other” medical care costs include primarily medically related administrative costs at the parent company. | |
MOLINA HEALTHCARE, INC. | ||||||||||||||||||||||||||
UNAUDITED SELECTED HEALTH PLANS SEGMENT FINANCIAL DATA—MARKETPLACE | ||||||||||||||||||||||||||
(In millions, except percentages and per-member per-month amounts) |
||||||||||||||||||||||||||
Three Months Ended March 31, 2018 | ||||||||||||||||||||||||||
Member Months |
Premium Revenue | Medical Care Costs | MCR |
Medical Margin |
||||||||||||||||||||||
Total | PMPM | Total | PMPM | |||||||||||||||||||||||
California | 0.2 | $ | 49 | $ | 253.93 | $ | 31 | $ | 162.64 | 64.0 | % | $ | 18 | |||||||||||||
Florida | 0.2 | 45 | 271.12 | (16 | ) | (95.60 | ) | (35.3 | ) | 61 | ||||||||||||||||
Michigan | 0.1 | 13 | 224.11 | 9 | 144.16 | 64.3 | 4 | |||||||||||||||||||
New Mexico | 0.1 | 34 | 438.67 | 19 | 246.50 | 56.2 | 15 | |||||||||||||||||||
Ohio | 0.1 | 26 | 403.44 | 17 | 262.87 | 65.2 | 9 | |||||||||||||||||||
Texas | 0.7 | 229 | 308.74 | 146 | 196.89 | 63.8 | 83 | |||||||||||||||||||
Utah (1) | — | (3 | ) | NM | (10 | ) | NM | NM | 7 | |||||||||||||||||
Washington | — | 39 | 526.36 | 30 | 405.40 | 77.0 | 9 | |||||||||||||||||||
Wisconsin (1) | — | (2 | ) | NM | (8 | ) | NM | NM | 6 | |||||||||||||||||
Other | — | — | — | — | — | — | — | |||||||||||||||||||
1.4 | $ | 430 | $ | 312.87 | $ | 218 | $ | 158.40 | 50.6 | % | $ | 212 | ||||||||||||||
Three Months Ended March 31, 2017 | ||||||||||||||||||||||||||
Member Months |
Premium Revenue | Medical Care Costs | MCR |
Medical Margin |
||||||||||||||||||||||
Total | PMPM | Total | PMPM | |||||||||||||||||||||||
California | 0.4 | $ | 72 | $ | 184.34 | $ | 26 | $ | 65.53 | 35.5 | % | $ | 46 | |||||||||||||
Florida | 1.0 | 292 | 292.80 | 206 | 205.91 | 70.3 | 86 | |||||||||||||||||||
Michigan | 0.1 | 11 | 149.23 | 6 | 95.92 | 64.3 | 5 | |||||||||||||||||||
New Mexico | 0.1 | 22 | 265.06 | 19 | 232.50 | 87.7 | 3 | |||||||||||||||||||
Ohio | 0.1 | 21 | 334.26 | 17 | 273.72 | 81.9 | 4 | |||||||||||||||||||
Texas | 0.7 | 157 | 222.40 | 113 | 161.02 | 72.4 | 44 | |||||||||||||||||||
Utah | 0.2 | 45 | 202.48 | 51 | 228.20 | 112.7 | (6 | ) | ||||||||||||||||||
Washington | 0.1 | 37 | 302.51 | 46 | 365.94 | 121.0 | (9 | ) | ||||||||||||||||||
Wisconsin | 0.2 | 94 | 453.39 | 81 | 389.80 | 86.0 | 13 | |||||||||||||||||||
Other | — | — | — | (1 | ) | — | — | 1 | ||||||||||||||||||
2.9 | $ | 751 | $ | 262.16 | $ | 564 | $ | 196.72 | 75.0 | % | $ | 187 | ||||||||||||||
__________________ |
||
(1) | We terminated Marketplace operations at our Utah and Wisconsin health plans effective January 1, 2018, so the ratios for 2018 periods are not meaningful for those health plans. | |
MOLINA HEALTHCARE, INC. | ||||||||||||||||||||||||||
UNAUDITED SELECTED HEALTH PLANS SEGMENT FINANCIAL DATA—TOTAL | ||||||||||||||||||||||||||
(In millions, except percentages and per-member per-month amounts) |
||||||||||||||||||||||||||
Three Months Ended March 31, 2018 | ||||||||||||||||||||||||||
Member Months |
Premium Revenue | Medical Care Costs | MCR |
Medical Margin |
||||||||||||||||||||||
Total | PMPM | Total | PMPM | |||||||||||||||||||||||
California | 2.0 | $ | 543 | $ | 270.80 | $ | 443 | $ | 221.03 | 81.6 | % | $ | 100 | |||||||||||||
Florida | 1.2 | 427 | 340.91 | 329 | 262.65 | 77.0 | 98 | |||||||||||||||||||
Idaho | — | 4 | 960.33 | 4 | 977.00 | 101.8 | — | |||||||||||||||||||
Illinois | 0.5 | 141 | 298.17 | 122 | 257.50 | 86.4 | 19 | |||||||||||||||||||
Michigan | 1.2 | 389 | 331.08 | 340 | 288.68 | 87.2 | 49 | |||||||||||||||||||
New Mexico | 0.8 | 353 | 463.33 | 329 | 431.94 | 93.2 | 24 | |||||||||||||||||||
New York | 0.1 | 46 | 468.91 | 39 | 396.76 | 84.6 | 7 | |||||||||||||||||||
Ohio | 1.0 | 577 | 565.62 | 477 | 467.41 | 82.6 | 100 | |||||||||||||||||||
Puerto Rico | 1.0 | 186 | 193.13 | 174 | 181.39 | 93.9 | 12 | |||||||||||||||||||
South Carolina | 0.3 | 122 | 348.08 | 104 | 297.52 | 85.5 | 18 | |||||||||||||||||||
Texas | 1.4 | 791 | 551.28 | 665 | 463.37 | 84.1 | 126 | |||||||||||||||||||
Utah | 0.3 | 89 | 328.83 | 67 | 246.78 | 75.0 | 22 | |||||||||||||||||||
Washington | 2.3 | 623 | 265.20 | 604 | 257.25 | 97.0 | 19 | |||||||||||||||||||
Wisconsin | 0.2 | 32 | 172.09 | 21 | 110.91 | 64.4 | 11 | |||||||||||||||||||
Other | — | — | — | 4 | — | — | (4 | ) | ||||||||||||||||||
12.3 | $ | 4,323 | $ | 350.25 | $ | 3,722 | $ | 301.55 | 86.1 | % | $ | 601 | ||||||||||||||
Three Months Ended March 31, 2017 | ||||||||||||||||||||||||||
Member Months |
Premium Revenue | Medical Care Costs | MCR |
Medical Margin |
||||||||||||||||||||||
Total | PMPM | Total | PMPM | |||||||||||||||||||||||
California | 2.2 | $ | 644 | $ | 286.92 | $ | 510 | $ | 227.19 | 79.2 | % | $ | 134 | |||||||||||||
Florida | 2.1 | 656 | 316.86 | 558 | 269.33 | 85.0 | 98 | |||||||||||||||||||
Idaho | — | — | — | — | — | — | — | |||||||||||||||||||
Illinois | 0.6 | 161 | 276.58 | 180 | 310.08 | 112.1 | (19 | ) | ||||||||||||||||||
Michigan | 1.3 | 393 | 316.80 | 339 | 273.36 | 86.3 | 54 | |||||||||||||||||||
New Mexico | 0.8 | 330 | 406.90 | 318 | 392.72 | 96.5 | 12 | |||||||||||||||||||
New York | 0.1 | 46 | 441.19 | 42 | 409.63 | 92.8 | 4 | |||||||||||||||||||
Ohio | 1.1 | 541 | 516.00 | 479 | 457.14 | 88.6 | 62 | |||||||||||||||||||
Puerto Rico | 1.0 | 183 | 186.51 | 165 | 168.18 | 90.2 | 18 | |||||||||||||||||||
South Carolina | 0.3 | 105 | 317.07 | 98 | 293.34 | 92.5 | 7 | |||||||||||||||||||
Texas | 1.4 | 684 | 486.96 | 602 | 428.55 | 88.0 | 82 | |||||||||||||||||||
Utah | 0.5 | 134 | 264.73 | 123 | 242.57 | 91.6 | 11 | |||||||||||||||||||
Washington | 2.3 | 642 | 274.74 | 581 | 248.40 | 90.4 | 61 | |||||||||||||||||||
Wisconsin | 0.4 | 127 | 311.30 | 108 | 264.53 | 85.0 | 19 | |||||||||||||||||||
Other | — | 2 | — | 8 | — | — | (6 | ) | ||||||||||||||||||
14.1 | $ | 4,648 | $ | 330.39 | $ | 4,111 | $ | 292.20 | 88.4 | % | $ | 537 | ||||||||||||||
MOLINA HEALTHCARE, INC. | |||||||||||||||||||||
UNAUDITED SELECTED HEALTH PLANS SEGMENT FINANCIAL DATA | |||||||||||||||||||||
(In millions, except percentages and per-member per-month amounts) |
|||||||||||||||||||||
The following tables provide the details of our medical care costs for the periods indicated: |
|||||||||||||||||||||
Three Months Ended March 31, | |||||||||||||||||||||
2018 | 2017 | ||||||||||||||||||||
% of | % of | ||||||||||||||||||||
Amount | PMPM | Total | Amount | PMPM | Total | ||||||||||||||||
Fee for service | $ | 2,745 | $ | 222.38 | 73.8 | % | $ | 3,086 | $ | 219.32 | 75.1 | % | |||||||||
Pharmacy | 583 | 47.25 | 15.6 | 616 | 43.76 | 15.0 | |||||||||||||||
Capitation | 312 | 25.28 | 8.4 | 324 | 23.06 | 7.9 | |||||||||||||||
Other | 82 | 6.64 | 2.2 | 85 | 6.06 | 2.0 | |||||||||||||||
$ | 3,722 | $ | 301.55 | 100.0 | % | $ | 4,111 | $ | 292.20 | 100.0 | % | ||||||||||
The following table provides the details of our medical claims and benefits payable as of the dates indicated: |
|||||||
March 31, | December 31, | ||||||
2018 | 2017 | ||||||
Fee-for-service claims incurred but not paid (IBNP) | $ | 1,586 | $ | 1,717 | |||
Pharmacy payable | 127 | 112 | |||||
Capitation payable | 62 | 67 | |||||
Other (1) | 248 | 296 | |||||
$ | 2,023 | $ | 2,192 | ||||
__________________ | ||
(1) | “Other” medical claims and benefits payable include amounts payable to certain providers for which we act as an intermediary on behalf of various state agencies without assuming financial risk. Such receipts and payments do not impact our consolidated statements of income. As of March 31, 2018 and December 31, 2017, we had recorded non-risk provider payables of approximately $146 million and $122 million, respectively. | |
UNAUDITED CHANGE IN MEDICAL
CLAIMS AND BENEFITS PAYABLE
(Dollars in millions, except
per-member amounts)
Our claims liability includes a provision for adverse claims deviation based on historical experience and other factors including, but not limited to, variations in claims payment patterns, changes in utilization and cost trends, known outbreaks of disease, and large claims. Our reserving methodology is consistently applied across all periods presented. The amounts displayed for “Components of medical care costs related to: Prior period” represent the amount by which our original estimate of claims and benefits payable at the beginning of the period was (more) less than the actual amount of the liability based on information (principally the payment of claims) developed since that liability was first reported. The following table presents the components of the change in medical claims and benefits payable for the periods indicated:
Three Months Ended March 31, |
Year Ended December 31, 2017 |
|||||||||||
2018 | 2017 | |||||||||||
Medical claims and benefits payable, beginning balance | $ | 2,192 | $ | 1,929 | $ | 1,929 | ||||||
Components of medical care costs related to: | ||||||||||||
Current period | 3,963 | 4,253 | 17,037 | |||||||||
Prior period | (241 | ) | (142 | ) | 36 | |||||||
Total medical care costs | 3,722 | 4,111 | 17,073 | |||||||||
Change in non-risk provider payables | 45 | (96 | ) | (106 | ) | |||||||
Payments for medical care costs related to: | ||||||||||||
Current period | 2,498 | 2,683 | 15,130 | |||||||||
Prior period | 1,438 | 1,335 | 1,574 | |||||||||
Total paid | 3,936 | 4,018 | 16,704 | |||||||||
Medical claims and benefits payable, ending balance | $ | 2,023 | $ | 1,926 | $ | 2,192 | ||||||
Benefit from prior period as a percentage of: | ||||||||||||
Balance at beginning of period | 11.0 | % | 7.4 | % | (1.9 | )% | ||||||
Premium revenue, trailing twelve months | 1.3 | % | 0.8 | % | (0.2 | )% | ||||||
Medical care costs, trailing twelve months | 1.4 | % | 0.9 | % | (0.2 | )% | ||||||
Days in claims payable, fee for service (1) | 53 | 45 | 54 | |||||||||
__________________ | ||
(1) | Claims payable includes primarily IBNP. Additionally, it includes certain fee-for-service payables reported in “Other” medical claims and benefits payable amounting to $22 million, $119 million and $99 million, as of March 31, 2018, 2017 and December 31, 2017, respectively. | |
UNAUDITED NON-GAAP FINANCIAL
MEASURES
We use non-generally accepted accounting principles, or non-GAAP, financial measures as supplemental metrics in evaluating our financial performance, making financing and business decisions, and forecasting and planning for future periods. For these reasons, management believes such measures are useful supplemental measures to investors in comparing our performance to the performance of other public companies in the health care industry. These non-GAAP financial measures should be considered as supplements to, and not as substitutes for or superior to, GAAP measures. See further information regarding non-GAAP measures below the tables (in millions, except per diluted share amounts).
Three Months Ended March 31, | ||||||||||||||||||||||
2018 | 2017 | |||||||||||||||||||||
Net income | $ | 107 | $ | 77 | ||||||||||||||||||
Adjustments: | ||||||||||||||||||||||
Depreciation, and amortization of intangible assets and capitalized software | 34 | 46 | ||||||||||||||||||||
Interest expense | 33 | 26 | ||||||||||||||||||||
Income tax expense | 72 | 54 | ||||||||||||||||||||
EBITDA | $ | 246 | $ | 203 | ||||||||||||||||||
Three Months Ended March 31, | ||||||||||||||||||||||
2018 | 2017 | |||||||||||||||||||||
Amount |
Per Diluted share |
Amount |
Per Diluted share |
|||||||||||||||||||
Net income | $ | 107 | $ | 1.64 | $ | 77 | $ | 1.37 | ||||||||||||||
Adjustment: | ||||||||||||||||||||||
Amortization of intangible assets | 5 | 0.08 | 9 | 0.16 | ||||||||||||||||||
Income tax effect (1) | (1 | ) | (0.01 | ) | (3 | ) | (0.06 | ) | ||||||||||||||
Amortization of intangible assets, net of tax effect | 4 | 0.07 | 6 | 0.10 | ||||||||||||||||||
Adjusted net income | $ | 111 | $ | 1.71 | $ | 83 | $ | 1.47 | ||||||||||||||
__________________ | ||
(1) | Income tax effect of adjustments calculated at the blended federal and state statutory tax rate of 22% and 37% for the first quarters of 2018 and 2017, respectively. | |
The following are descriptions of the adjustments made to GAAP measures used to calculate the non-GAAP measures used in this news release:
Earnings before interest, taxes, depreciation and amortization (EBITDA): Net income (GAAP) less depreciation, and amortization of intangible assets and capitalized software, interest expense and income tax expense. We believe that EBITDA is helpful in assessing our ability to meet the cash demands of our operating units.
Adjusted net income: Net income (GAAP) less amortization of intangible assets, net of income tax effect calculated at the statutory tax rate. We believe that adjusted net income is helpful in assessing our financial performance exclusive of the non-cash impact of the amortization of purchased intangibles.
Adjusted net income per diluted share: Adjusted net income divided by weighted average common shares outstanding on a fully diluted basis.
MOLINA HEALTHCARE, INC. | |||||||||||||||||
2018 REVISED GUIDANCE | |||||||||||||||||
Reconciliation of Non-GAAP Financial Measures | |||||||||||||||||
(in millions, except per-share amounts) |
|||||||||||||||||
Low End | High End | ||||||||||||||||
Net income | $ | 272 | $ | 306 | |||||||||||||
Adjustments: | |||||||||||||||||
Depreciation, and amortization of intangible assets and capitalized software | 148 | 148 | |||||||||||||||
Interest expense | 125 | 125 | |||||||||||||||
Income tax expense | 179 | 189 | |||||||||||||||
EBITDA | $ | 724 | $ | 768 | |||||||||||||
Low End | High End | ||||||||||||||||
Amount | Per share (2) | Amount | Per share (2) | ||||||||||||||
Net income | $ | 272 | $ | 4.00 | $ | 306 | $ | 4.50 | |||||||||
Adjustments: | |||||||||||||||||
Amortization of intangible assets | 21 | 0.31 | 21 | 0.31 | |||||||||||||
Income tax effect (1) | (5 | ) | (0.07 | ) | (5 | ) | (0.07 | ) | |||||||||
Amortization of intangible assets, net of tax effect | 16 | 0.24 | 16 | 0.24 | |||||||||||||
Adjusted net income | $ | 288 | $ | 4.24 | $ | 322 | $ | 4.74 | |||||||||
__________________ | ||
(1) | Income tax effect calculated at the statutory tax rate of 22%. | |
(2) | Computation assumes 68.0 million diluted weighted average shares outstanding. | |
View source version on businesswire.com: https://www.businesswire.com/news/home/20180430005361/en/
Source:
Molina Healthcare, Inc.
Ryan Kubota, 562-435-3666, ext. 119057
Investor
Relations